CollPlant Biotechnologies Statistics
Total Valuation
CLGN has a market cap or net worth of $47.88 million. The enterprise value is $32.92 million.
Important Dates
The next confirmed earnings date is Wednesday, November 27, 2024, before market open.
Earnings Date | Nov 27, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
CLGN has 11.45 million shares outstanding. The number of shares has increased by 1.97% in one year.
Current Share Class | 11.45M |
Shares Outstanding | 11.45M |
Shares Change (YoY) | +1.97% |
Shares Change (QoQ) | +0.01% |
Owned by Insiders (%) | 30.97% |
Owned by Institutions (%) | 17.60% |
Float | 7.82M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 70.30 |
Forward PS | 39.06 |
PB Ratio | 2.34 |
P/TBV Ratio | 2.36 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 47.78 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.27, with a Debt / Equity ratio of 0.16.
Current Ratio | 6.27 |
Quick Ratio | 6.07 |
Debt / Equity | 0.16 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -61.55% and return on invested capital (ROIC) is -36.23%.
Return on Equity (ROE) | -61.55% |
Return on Assets (ROA) | -33.77% |
Return on Capital (ROIC) | -36.23% |
Revenue Per Employee | $9,187 |
Profits Per Employee | -$232,947 |
Employee Count | 75 |
Asset Turnover | 0.02 |
Inventory Turnover | 2.14 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.46% in the last 52 weeks. The beta is 0.48, so CLGN's price volatility has been lower than the market average.
Beta (5Y) | 0.48 |
52-Week Price Change | -24.46% |
50-Day Moving Average | 4.37 |
200-Day Moving Average | 5.03 |
Relative Strength Index (RSI) | 52.10 |
Average Volume (20 Days) | 16,494 |
Short Selling Information
Short Interest | 15,431 |
Short Previous Month | 14,451 |
Short % of Shares Out | 0.20% |
Short % of Float | n/a |
Short Ratio (days to cover) | 1.38 |
Income Statement
In the last 12 months, CLGN had revenue of $689,000 and -$17.47 million in losses. Loss per share was -$1.53.
Revenue | 689,000 |
Gross Profit | -1.44M |
Operating Income | -18.41M |
Pretax Income | -7.50M |
Net Income | -17.47M |
EBITDA | -17.31M |
EBIT | -18.41M |
Loss Per Share | -$1.53 |
Full Income Statement Balance Sheet
The company has $18.92 million in cash and $3.39 million in debt, giving a net cash position of $15.54 million or $1.36 per share.
Cash & Cash Equivalents | 18.92M |
Total Debt | 3.39M |
Net Cash | 15.54M |
Net Cash Per Share | $1.36 |
Equity (Book Value) | 20.73M |
Book Value Per Share | 1.81 |
Working Capital | 17.09M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$2.75 million and capital expenditures -$756,000, giving a free cash flow of -$3.51 million.
Operating Cash Flow | -2.75M |
Capital Expenditures | -756,000 |
Free Cash Flow | -3.51M |
FCF Per Share | -$0.31 |
Full Cash Flow Statement Margins
Gross Margin | -209.43% |
Operating Margin | -2,671.26% |
Pretax Margin | -2,535.70% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -31.90% |
Dividends & Yields
CLGN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.97% |
Shareholder Yield | -1.97% |
Earnings Yield | -36.06% |
FCF Yield | -7.24% |
Analyst Forecast
The average price target for CLGN is $12.50, which is 199.04% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $12.50 |
Price Target Difference | 199.04% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on November 21, 2016. It was a reverse split with a ratio of 0.6666666:1.
Last Split Date | Nov 21, 2016 |
Split Type | Reverse |
Split Ratio | 0.6666666:1 |
Scores
CLGN has an Altman Z-Score of -0.25 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.25 |
Piotroski F-Score | 1 |